221
Participants
Start Date
October 31, 2011
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Imiquimod
One course of treatment (COT) consisting of an overnight application of IMIQ (1 sachet for up to 50 cm2), applied 3 nights per week (e.g. Monday, Wednesday, Friday) for 4 weeks followed by a 4 weeks treatment pause. If necessary, this may be followed by a second COT.
Diclofenac
Solaraze® is applied locally to the skin 2 times daily and smoothed into the skin gently. The amount needed depends on the size of the lesion. Normally 0.5 grams (the size of a pea) of the gel is used on a 25 cm2 lesion site. The duration of therapy is 12 weeks.
Medical University Graz, University Clinic for Dermatology and Venerology Graz, Graz
Medical Practice, Maria Enzersdorf
Medical University Vienna, Department for General Dermatology, Vienna
Medical Supply Center, Augsburg
Licca Clinical Research Institute, Clinic for Dermatolgy and Surgery, Augsburg
Medical Practice, Berlin
Medical Practice, Dülmen
Medical Practice, Germering
Medical Department of Otto-von-Guericke-University Magdeburg, University Clinic for Dermatology and Venerology, Magdeburg
Medical Practice, Mahlow
Department of Dermatology Johannes Gutenberg-University Mainz, Clinical Research Center, Mainz
Medical Practice, Markkleeberg
Medical Practice for Dermatology and Medical Cosmetics, Mönchengladbach
Medical Practice, Münster
Derma Center Vechta, Clinic for Dermatology, Vechta
Centrovital, Medical Practice for Dermatology, Witten
Medical Practice for Dermatology and Venerology, Wuppertal
Collaborators (1)
Siro Clinpharm Germany GmbH (until June 2013)
UNKNOWN
Accovion GmbH
INDUSTRY
MEDA Pharma GmbH & Co. KG
INDUSTRY